title: Cost effectiveness of vaccinating food service workers against hepatitis A infection.
abstract: Foodborne transmission is an important means of hepatitis A infection that may be reduced through vaccination of food service workers (FSWs). Several states are considering actions to encourage or mandate FSW vaccination, but the cost effectiveness of such policies has not been assessed. We estimated the clinical and economic consequences of vaccinating FSWs from the 10 states with the highest reported rates of hepatitis A. A decision analytic model was used to predict the effects of vaccinating FSWs at age 20 years. It was assumed all FSWs would receive one dose of inactivated hepatitis A vaccine, and 50% would receive the second recommended dose. Parameter estimates were obtained from published reports and Centers for Disease Control and Prevention databases. The primary endpoint was cost per year of life saved (YOLS). Secondary endpoints were symptomatic infections, days of illness, deaths, and costs of hepatitis A treatment, public health intervention, and work loss. Each endpoint was considered separately for FSWs and patrons. We estimate vaccination of 100,000 FSWs would cost $8.1 million but reduce the costs of hepatitis A treatment, public health intervention, and work loss by $3.0 million, $2.3 million, and $3.1 million, respectively. Vaccination would prevent approximately 2,500 symptomatic infections, 93,000 days of illness, and 8 deaths. A vaccination policy would reduce societal costs while costing the health system $13,969 per YOLS, a ratio that exceeds generally accepted standards of cost effectiveness.
authors.affiliation: Capitol Outcomes Research, Inc, Alexandria, Virginia 22310 , USA. JAKEatCOR@aol.com
authors.forename: R J
authors.initials: RJ
authors.lastname: Jacobs
authors.forename: S F
authors.initials: SF
authors.lastname: Grover
authors.forename: A S
authors.initials: AS
authors.lastname: Meyerhoff
authors.forename: T A
authors.initials: TA
authors.lastname: Paivana
mesh_terms: D000328:Adult; D000368:Aged; D003362:Cost-Benefit Analysis; D005525:Food-Processing Industry; D006506:Hepatitis A / Q000517:prevention & control / Q000635:transmission; D022362:Hepatitis A Vaccines; D006801:Humans; D008875:Middle Aged; D016273:Occupational Exposure; D014611:Vaccination / Q000191:economics; D014761:Viral Hepatitis Vaccines / Q000191:economics*
chemical_list: D022362:Hepatitis A Vaccines; D014761:Viral Hepatitis Vaccines